PURPOSE: To investigate the age range for which cycloplegia provides additional information compared with non-cycloplegic refraction in teenagers and young adults. METHODS: Data for 1295 subjects (704 female; 591 male) from the Twins Eye Study in Tasmania (TEST) and the Brisbane Adolescent Twin Study (mean age: 19.65 ± 3.56, range: 13-26 years) were included. For all participants, cycloplegia was induced by instillation of either one drop of 1% cyclopentolate (13-14 years) or one drop of 1% tropicamide (15-26 years). Pre- and postcycloplegic refractive errors for both eyes were measured using a Humphrey-598 automated refractor and spherical equivalents of refractive error were calculated. Generalized Estimating Equations (GEE) were used to model the spherical equivalent refraction (SER) for each eye against age (by year) and axial length (in the given eye). RESULTS: The mean group difference between pre- and postcycloplegic SER (post minus pre) was 0.17 ± 0.52 D and 0.12 ± 0.51 D for the right and left eyes, respectively, indicating that postcycloplegic refraction was generally more hyperopic/less myopic. The mean difference between pre- and postcycloplegic SER decreased from 0.36 ± 0.41 D in the 13-year-olds to 0.06 ± 0.50 D in people aged 25 years. After adjusting for family-relatedness, the difference between pre- and postcycloplegia SER was significant in all age groups up until the age of 20 years. CONCLUSIONS: Non-cycloplegic autorefraction can result in group mean SER differences of greater myopia than cycloplegic autorefraction and occurs in teenagers (13-19 years of age), but not in adults 20-26 years. These data suggest that cycloplegia is not required in population estimates of refractive error for young adults once they reach approximately 20 years of age.
PURPOSE: To investigate the age range for which cycloplegia provides additional information compared with non-cycloplegic refraction in teenagers and young adults. METHODS: Data for 1295 subjects (704 female; 591 male) from the Twins Eye Study in Tasmania (TEST) and the Brisbane Adolescent Twin Study (mean age: 19.65 ± 3.56, range: 13-26 years) were included. For all participants, cycloplegia was induced by instillation of either one drop of 1% cyclopentolate (13-14 years) or one drop of 1% tropicamide (15-26 years). Pre- and postcycloplegic refractive errors for both eyes were measured using a Humphrey-598 automated refractor and spherical equivalents of refractive error were calculated. Generalized Estimating Equations (GEE) were used to model the spherical equivalent refraction (SER) for each eye against age (by year) and axial length (in the given eye). RESULTS: The mean group difference between pre- and postcycloplegic SER (post minus pre) was 0.17 ± 0.52 D and 0.12 ± 0.51 D for the right and left eyes, respectively, indicating that postcycloplegic refraction was generally more hyperopic/less myopic. The mean difference between pre- and postcycloplegic SER decreased from 0.36 ± 0.41 D in the 13-year-olds to 0.06 ± 0.50 D in people aged 25 years. After adjusting for family-relatedness, the difference between pre- and postcycloplegia SER was significant in all age groups up until the age of 20 years. CONCLUSIONS: Non-cycloplegic autorefraction can result in group mean SER differences of greater myopia than cycloplegic autorefraction and occurs in teenagers (13-19 years of age), but not in adults 20-26 years. These data suggest that cycloplegia is not required in population estimates of refractive error for young adults once they reach approximately 20 years of age.
Authors: János Németh; Tennó Daiki; Gergely Dankovics; István Barna; Hans Limburg; Zoltán Zsolt Nagy Journal: Int J Ophthalmol Date: 2022-07-18 Impact factor: 1.645
Authors: Phillippa M Cumberland; Yanchun Bao; Pirro G Hysi; Paul J Foster; Christopher J Hammond; Jugnoo S Rahi Journal: PLoS One Date: 2015-10-02 Impact factor: 3.240
Authors: Katie M Williams; Geir Bertelsen; Phillippa Cumberland; Christian Wolfram; Virginie J M Verhoeven; Eleftherios Anastasopoulos; Gabriëlle H S Buitendijk; Audrey Cougnard-Grégoire; Catherine Creuzot-Garcher; Maja Gran Erke; Ruth Hogg; René Höhn; Pirro Hysi; Anthony P Khawaja; Jean-François Korobelnik; Janina Ried; Johannes R Vingerling; Alain Bron; Jean-François Dartigues; Astrid Fletcher; Albert Hofman; Robert W A M Kuijpers; Robert N Luben; Konrad Oxele; Fotis Topouzis; Therese von Hanno; Alireza Mirshahi; Paul J Foster; Cornelia M van Duijn; Norbert Pfeiffer; Cécile Delcourt; Caroline C W Klaver; Jugnoo Rahi; Christopher J Hammond Journal: Ophthalmology Date: 2015-05-13 Impact factor: 12.079
Authors: Jeremy A Guggenheim; Beate St Pourcain; George McMahon; Nicholas J Timpson; David M Evans; Cathy Williams Journal: Mol Vis Date: 2015-05-26 Impact factor: 2.367
Authors: Katie M Williams; Virginie J M Verhoeven; Phillippa Cumberland; Geir Bertelsen; Christian Wolfram; Gabriëlle H S Buitendijk; Albert Hofman; Cornelia M van Duijn; Johannes R Vingerling; Robert W A M Kuijpers; René Höhn; Alireza Mirshahi; Anthony P Khawaja; Robert N Luben; Maja Gran Erke; Therese von Hanno; Omar Mahroo; Ruth Hogg; Christian Gieger; Audrey Cougnard-Grégoire; Eleftherios Anastasopoulos; Alain Bron; Jean-François Dartigues; Jean-François Korobelnik; Catherine Creuzot-Garcher; Fotis Topouzis; Cécile Delcourt; Jugnoo Rahi; Thomas Meitinger; Astrid Fletcher; Paul J Foster; Norbert Pfeiffer; Caroline C W Klaver; Christopher J Hammond Journal: Eur J Epidemiol Date: 2015-03-18 Impact factor: 8.082
Authors: Dan Zhu; Yan Wang; Xianrong Yang; Dayong Yang; Kai Guo; Yuanyuan Guo; Xinxia Jing; Chen-Wei Pan Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240
Authors: Edward Mountjoy; Neil M Davies; Denis Plotnikov; George Davey Smith; Santiago Rodriguez; Cathy E Williams; Jeremy A Guggenheim; Denize Atan Journal: BMJ Date: 2018-06-06